Devyser Genomic Laboratories receives Accreditation from College of American Pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
At present, FH is greatly underdiagnosed, and most cases are not discovered until the affected individual suffers his or her first cardiovascular event.
This paper by Peter Benedek and Kristina Duvefelt, Karolinska University Hospital, Stockholm, Sweden, introduces the clinical diagnosis, indicators and symptoms, and treatment of FH, before examining the background and current status of genetic testing for FH, and new best practices enabled by Next Generation Sequencing.
At present, FH is greatly underdiagnosed, and most cases are not discovered until the affected individual suffers his or her first cardiovascular event.
This paper by Peter Benedek and Kristina Duvefelt, Karolinska University Hospital, Stockholm, Sweden, introduces the clinical diagnosis, indicators and symptoms, and treatment of FH, before examining the background and current status of genetic testing for FH, and new best practices enabled by Next Generation Sequencing.
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Read More
Read More
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Read More
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More